Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS) - Langdahl, BL; Rajzbaum, G; Jakob, F (Calcif Tissue Int, 2009)
et al.